INTRODUCTION INTRODUCTION
Diabetes mellitus is a complex and progresDiabetes mellitus is a complex and progressive metabolic disorder that is characterised sive metabolic disorder that is characterised by persistent hyperglycaemia caused by by persistent hyperglycaemia caused by insulin deficiency and/or insulin resistance. insulin deficiency and/or insulin resistance. It has been estimated that in 2003 nearly It has been estimated that in 2003 nearly 190 million people worldwide had diabetes. 190 million people worldwide had diabetes. By 2025, that figure is predicted to increase By 2025, that figure is predicted to increase by 72% to 324 million. Studies in the USA by 72% to 324 million. Studies in the USA have found rates of known diabetes in the have found rates of known diabetes in the general population of between 1.2% and general population of between 1.2% and 6.3% depending upon age and ethnicity. 6.3% depending upon age and ethnicity. In the UK, 1.4 million people are known In the UK, 1.4 million people are known to have diabetes; another 1 million are to have diabetes; another 1 million are thought to have undiagnosed diabetes. thought to have undiagnosed diabetes. The prevalence of impaired glucose tolerThe prevalence of impaired glucose tolerance, a pre-diabetic state of impaired ance, a pre-diabetic state of impaired glucose metabolism, may be 2-3 times glucose metabolism, may be 2-3 times higher than that of diabetes. higher than that of diabetes.
Type 2 diabetes, the most common form Type 2 diabetes, the most common form of diabetes, results from an interaction of diabetes, results from an interaction between a genetic predisposition and envirbetween a genetic predisposition and environmental factors such as a poor diet and a onmental factors such as a poor diet and a sedentary lifestyle. Early detection and sedentary lifestyle. Early detection and treatment of type 2 diabetes is essential to treatment of type 2 diabetes is essential to prevent the long-term complications. It is prevent the long-term complications. It is thought that the pathological process that thought that the pathological process that leads to the development of type 2 diabetes leads to the development of type 2 diabetes starts on average 10-15 years before diagstarts on average 10-15 years before diagnosis. Since type 2 diabetes is generally nosis. Since type 2 diabetes is generally asymptomatic, the emphasis must be on asymptomatic, the emphasis must be on effective screening programmes, especially effective screening programmes, especially in high-risk groups. in high-risk groups.
The interaction between diabetes and The interaction between diabetes and schizophrenia is complex. Many people schizophrenia is complex. Many people with schizophrenia have multiple risk with schizophrenia have multiple risk factors for type 2 diabetes, such as a family factors for type 2 diabetes, such as a family history of diabetes, higher-risk ethnic history of diabetes, higher-risk ethnic origin, obesity, sedentary lifestyle and origin, obesity, sedentary lifestyle and smoking. It has also been suggested that smoking. It has also been suggested that the condition itself might be an additional the condition itself might be an additional risk factor for diabetes, as may antirisk factor for diabetes, as may antipsychotic treatment. Consequently, people psychotic treatment. Consequently, people with schizophrenia may represent an with schizophrenia may represent an independent high-risk group for diabetes. independent high-risk group for diabetes.
Much conflicting data have been pubMuch conflicting data have been published on the relationship between lished on the relationship between schizophrenia, antipsychotics and diabetes, schizophrenia, antipsychotics and diabetes, resulting in a lack of consensus on the issue. resulting in a lack of consensus on the issue. Little has been done to propose a pragmatic Little has been done to propose a pragmatic pathway for managing diabetes risks in pathway for managing diabetes risks in people with mental illness. For these people with mental illness. For these reasons, an international group of experts reasons, an international group of experts in psychiatry and diabetic medicine was in psychiatry and diabetic medicine was convened in order to review the evidence convened in order to review the evidence to date and answer the following questions. to date and answer the following questions. This document summarises the group's This document summarises the group's collective view on these issues. It is hoped collective view on these issues. It is hoped that by clarifying some of the controversial that by clarifying some of the controversial areas, the quality of care available to people areas, the quality of care available to people with schizophrenia will be improved in the with schizophrenia will be improved in the future. future.
WHAT IS THE EFFECT WHAT IS THE EFFECT
The prevalence of type 2 diabetes in people The prevalence of type 2 diabetes in people with schizophrenia can be 2-4 times higher with schizophrenia can be 2-4 times higher than in the general population. The precise than in the general population. The precise prevalence can be reasonably estimated to prevalence can be reasonably estimated to be approximately 15-18%. The prevalence be approximately 15-18%. The prevalence of impaired glucose tolerance in people of impaired glucose tolerance in people with schizophrenia may be as high as with schizophrenia may be as high as 30%, depending upon age. A high preva-30%, depending upon age. A high prevalence of diabetes and impaired glucose lence of diabetes and impaired glucose tolerance is also seen in other severe mental tolerance is also seen in other severe mental illnesses such as bipolar disorder. The preillnesses such as bipolar disorder. The prevalence of type 2 diabetes in people with valence of type 2 diabetes in people with bipolar disorder can be 2-3 times that in bipolar disorder can be 2-3 times that in the general population. the general population.
As many as two-thirds of cases of diaAs many as two-thirds of cases of diabetes and impaired glucose tolerance may betes and impaired glucose tolerance may currently go unidentified in people with currently go unidentified in people with schizophrenia, as screening is not underschizophrenia, as screening is not undertaken routinely. taken routinely.
Type 2 diabetes and impaired glucose Type 2 diabetes and impaired glucose tolerance may be present in people with tolerance may be present in people with schizophrenia prior to their exposure to schizophrenia prior to their exposure to any antipsychotic drug treatment. An assoany antipsychotic drug treatment. An association between severe mental illnesses and ciation between severe mental illnesses and impaired glucose metabolism was identified impaired glucose metabolism was identified many decades before the introduction of many decades before the introduction of antipsychotic medications. In one of the antipsychotic medications. In one of the most recent studies, impaired fasting most recent studies, impaired fasting glycaemia was reported in young, firstglycaemia was reported in young, firstepisode, drug-naıve schizophrenia patients. episode, drug-naïve schizophrenia patients.
The relationship between schizophrenia The relationship between schizophrenia and diabetes is not fully understood. An and diabetes is not fully understood. An association between the two conditions association between the two conditions was recognised in the pre-antipsychotic was recognised in the pre-antipsychotic era. Schizophrenia and diabetes may share era. Schizophrenia and diabetes may share a common aetiology and/or pathogenic mea common aetiology and/or pathogenic mechanisms. Many people with schizophrenia chanisms. Many people with schizophrenia have a diet high in saturated fat and sugar have a diet high in saturated fat and sugar and low in fibre (which is known to preciand low in fibre (which is known to precipitate many of the conditions associated pitate many of the conditions associated with the metabolic syndrome), smoke and with the metabolic syndrome), smoke and take little exercise. They are also up to take little exercise. They are also up to three times more likely to have a family histhree times more likely to have a family history of type 2 diabetes than the general tory of type 2 diabetes than the general population. It seems likely therefore that population. It seems likely therefore that type 2 diabetes develops as a result of entype 2 diabetes develops as a result of environmental and lifestyle factors in people vironmental and lifestyle factors in people who are genetically predisposed to disease. who are genetically predisposed to disease.
There is cumulative evidence that There is cumulative evidence that schizophrenia is an independent risk factor schizophrenia is an independent risk factor for diabetes. for diabetes.
WHAT IS THE EFFECT WHAT IS THE EFFECT OF ANTIPSYCHOTICS OF ANTIPSYCHOTICS ON GLUCOSE METABOLISM ? ON GLUCOSE METABOLISM ?
Antipsychotic treatment is essential for the Antipsychotic treatment is essential for the well-being of people with schizophrenia. well-being of people with schizophrenia. Effectiveness should be the most important Effectiveness should be the most important consideration when selecting antipsychotic consideration when selecting antipsychotic treatment. treatment.
Idiosyncratic cases of diabetic ketoaciIdiosyncratic cases of diabetic ketoacidosis have been reported with both typical dosis have been reported with both typical and atypical antipsychotics. Case reports and atypical antipsychotics. Case reports can be found even with the latest atypical can be found even with the latest atypical agents in spite of their relatively small usage. agents in spite of their relatively small usage.
All atypical antipsychotics have been All atypical antipsychotics have been associated with impaired glucose metaboassociated with impaired glucose metabolism. Published evidence to date shows lism. Published evidence to date shows no convincing difference between agents, no convincing difference between agents, and impaired glucose metabolism is now and impaired glucose metabolism is now considered to be a class effect. considered to be a class effect.
Atypical antipsychotics, especially cloAtypical antipsychotics, especially clozapine, may have a stronger association with zapine, may have a stronger association with impaired glucose metabolism than typical impaired glucose metabolism than typical antipsychotics. However, this difference antipsychotics. However, this difference s11 2 s112 Other factors such as severe mental illOther factors such as severe mental illness and associated lifestyle issues may be ness and associated lifestyle issues may be contributing more to the high prevalence contributing more to the high prevalence of impaired glucose metabolism seen in peoof impaired glucose metabolism seen in people with schizophrenia than drug treatment. ple with schizophrenia than drug treatment.
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY
The mechanisms by which antipsychoThe mechanisms by which antipsychotics may influence glucose metabolism are tics may influence glucose metabolism are unknown. In published studies, albeit unknown. In published studies, albeit short-term ones, no association has been short-term ones, no association has been found between treatment-related weight found between treatment-related weight gain and diabetes. However, since obesity gain and diabetes. However, since obesity is a risk factor for diabetes, weight manageis a risk factor for diabetes, weight management and a healthy lifestyle should be ment and a healthy lifestyle should be encouraged in all patients at risk of encouraged in all patients at risk of developing diabetes, including those with developing diabetes, including those with schizophrenia. schizophrenia.
The available evidence supports an The available evidence supports an association between antipsychotics and association between antipsychotics and impaired glucose metabolism but does not impaired glucose metabolism but does not establish causality. Most studies to date establish causality. Most studies to date have been retrospective, and these have a have been retrospective, and these have a number of limitations, including detection number of limitations, including detection and selection bias and an inability to control and selection bias and an inability to control for confounding risk factors. Prospective, for confounding risk factors. Prospective, randomised trials allow more accurate randomised trials allow more accurate between-treatment comparisons. Long-term between-treatment comparisons. Long-term prospective studies need to be undertaken in prospective studies need to be undertaken in order to provide definitive answers. order to provide definitive answers.
HOW SHOULD DIABETES HOW SHOULD DIABETES RISKS BE MANAGED RISKS BE MANAGED IN PEOPLE WITH IN PEOPLE WITH SCHIZOPHRENIA? SCHIZOPHRENIA?
Health care professionals should be aware Health care professionals should be aware that people with severe mental illness such that people with severe mental illness such as schizophrenia are a high-risk group for as schizophrenia are a high-risk group for developing diabetes. developing diabetes.
Timely screening and effective manageTimely screening and effective management of risk factors are vital for the early ment of risk factors are vital for the early detection of impaired glucose tolerance detection of impaired glucose tolerance and diabetes and for the reduction of and diabetes and for the reduction of disease progression and development of disease progression and development of complications. complications.
Mental health teams should take on Mental health teams should take on some responsibility for managing general some responsibility for managing general health issues in their patients, e.g. providing health issues in their patients, e.g. providing education about healthy living, ensuring education about healthy living, ensuring that screening for diabetes is done and that that screening for diabetes is done and that other services are involved when necessary. other services are involved when necessary.
Mental health teams should be aware of Mental health teams should be aware of local guidelines for the screening and local guidelines for the screening and management of diabetes. If screening promanagement of diabetes. If screening programmes do not exist, they should consider grammes do not exist, they should consider establishing their own programmes in establishing their own programmes in consultation with primary care teams and consultation with primary care teams and diabetes specialist services. diabetes specialist services.
Well-defined responsibilities and good Well-defined responsibilities and good communication between mental health communication between mental health teams, primary care teams and diabetes teams, primary care teams and diabetes specialist services will be critical to reduspecialist services will be critical to reducing the burden of diabetes in people with cing the burden of diabetes in people with schizophrenia. schizophrenia. (i) general practitioner (GP) or diabetes (i) general practitioner (GP) or diabetes specialist services to continue to specialist services to continue to manage the diabetes; manage the diabetes;
Proposed pragmatic pathways for
(ii) mental health teams to continue to (ii) mental health teams to continue to manage the mental illness; manage the mental illness;
(iii) patient to continue with home (iii) patient to continue with home blood glucose monitoring as usual; blood glucose monitoring as usual;
(iv) communicate any issues between (iv) communicate any issues between services. services. 
